Ironwood Pharmaceuticals (IRWD) EBITDA (2009 - 2026)
Ironwood Pharmaceuticals' EBITDA was $79.76 million in Q2 2026, up 74.2% from $45.79 million a year earlier and up 9.2% from the prior quarter.
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ironwood Pharmaceuticals' EBITDA was $236 million through Jun 30, 2026, up 210.4% year-over-year; for FY2025, it was $99.6 million, up 3.5% from FY2024.
- EBITDA shows a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
- In earlier years, EBITDA was $96.23 million in FY2024, -$942.17 million in FY2023, $253.59 million in FY2022 (-1.6%) and $257.69 million in FY2021 (+53.8%).
- The Q2 2026 figure marks the highest quarterly EBITDA since Q4 2017.
- Compared with a year earlier, EBITDA was higher in three of the last six quarters, with growth averaging 34.6%.
- The best year-over-year quarter for EBITDA over five years was Q3 2025 (growth of 186.7%); the worst was Q1 2024 (a decline of 80.1%).
- Per Business Quant data, IRWD's EBITDA in the three quarters before Q2 2026 was $73.02 million (Q1 2026), $7.27 million (Q4 2025) and $75.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Ironwood Pharmaceuticals | 796.30 Mn | 194.87 Mn | - | 93.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 93.84 Mn |
| Jun 30, 2026 | 80.15 Mn |
| Mar 31, 2026 | 73.44 Mn |
| Dec 31, 2025 | 7.68 Mn |
| Sep 30, 2025 | 76.38 Mn |
| Jun 30, 2025 | 46.20 Mn |
| Mar 31, 2025 | -28.21 Mn |
| Dec 31, 2024 | 32.39 Mn |
| Sep 30, 2024 | 26.49 Mn |
| Jun 30, 2024 | 26.03 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Dec 31, 2023 | 38.69 Mn |
| Sep 30, 2023 | 41.12 Mn |
| Jun 30, 2023 | -1.08 Bn |
| Mar 31, 2023 | 60.79 Mn |
| Dec 31, 2022 | 69.10 Mn |
| Sep 30, 2022 | 69.24 Mn |
| Jun 30, 2022 | 56.53 Mn |
| Mar 31, 2022 | 58.74 Mn |
| Dec 31, 2021 | 63.10 Mn |
API Access
Ironwood Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IRWD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IRWD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IRWD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();